https://orcid.org/0000-0002-6620-8547
References
- World Health Organization. Global tuberculosis report 2016; 2016
- Kebede F, Kebede B, Kebede T, Agmasu M, Wang M. Effect of isoniazid preventive therapy on the incidence of tuberculosis among seropositive children attending HIV/AIDS care in two general hospitals, Northwest Ethiopia, 2021. J Trop Med. 2021;2021:9996953. doi:10.1155/2021/9996953
- Mardani M. TB/HIV co-infection. Iran J Clin Infect Dis. 2007;2(4):167–168.
- Ethiopian Federal Ministry of Health. Guidelines for Clinical and Programmatic Management of TB, TB / HIV, DR-TB and Leprosy in Ethiopia. TBL Guide; August, 2021:1–249.
- World Health Organization. G Global Tuberculosis Control. Control; 2010.
- UNAIDS. Fact Sheet_World Tuberculosis Day; 2022.
- World Health Organization. Guidelines for Intensified Tuberculosis Case-Finding and Isoniazid Preventive Therapy for People Living with HIV in Resource Constrained Settings; 2011.
- Godfrey-faussett P. Policy statement on preventive therapy against tuberculosis in people living with HIV; February, 1998.
- World Health Organization. Implementing the WHO Stop TB Strategy: A Hand Book for National TB Control Programmes; 2008.
- Zeleke ED, Ejigu DA, Assefa DG, et al. Isoniazid Preventive Therapy for Prevention of Tuberculosis Among People Living with HIV in Ethiopia: a Systematic Review of Implementation and Impacts. Int J Environ Res Public Health. 2022;20(1):621.
- WHO. Tuberculosis Report. Vol. XLIX. Baltimore Health News; 2020:8.
- Beshaw MA, Balcha SA, Lakew AM. Effect of Isoniazid Prophylaxis Therapy on the Prevention of Tuberculosis Incidence and Associated Factors Among HIV Infected Individuals in Northwest Ethiopia: retrospective Cohort Study. HIV AIDS. 2021;13:617–629.
- Geremew D, Endalamaw A, Negash M, Eshetie S, Tessema B. The protective effect of isoniazid preventive therapy on tuberculosis incidence among HIV positive patients receiving ART in Ethiopian settings: a meta-analysis. BMC Infect Dis. 2019;19(1):405. doi:10.1186/s12879-019-4031-2
- Alemu A, Yesuf A, Zerihun B, Getu M, Worku T, Bitew ZW. Incidence and determinants of tuberculosis among HIV-positive individuals in Addis Ababa, Ethiopia: a retrospective cohort study. Int J Infect Dis. 2020;95:59–66.
- Havlir D, Lockman S, Ayles H, Larmarange J, Chamie G. What do the Universal Test and Treat trials tell us about the path to HIV epidemic control ?. J Int AIDS Soc. 2020;23(2):e25455.
- Support WHO, Country FOR. PROGRESS REPORT 2016; 2016.
- Getu A, Wolde HF, Animut Y, Kibret AA, Quinn F. Incidence and predictors of Tuberculosis among patients enrolled in Anti-Retroviral Therapy after universal test and treat program, Addis Ababa, Ethiopia. A retrospective follow -up study. PLoS One. 2022;17(8):1–13. doi:10.1371/journal.pone.0272358
- FMOH Ethiopia. National Consolidated Guidelines for Comprehensive HIV Prevention, Care and; 2018;1–238.
- Pham BN, Abori N, Silas VD, et al. Tuberculosis and HIV/AIDS-attributed mortalities and associated sociodemographic factors in Papua New Guinea: evidence from the comprehensive health and epidemiological surveillance system. BMJ Open. 2022;12(6):e058962. doi:10.1136/bmjopen-2021-058962
- Semu M, Fenta TG, Medhin G, Assefa D. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study. BMC Infect Dis. 2017;17(1):1–8. doi:10.1186/s12879-016-2109-7
- Kazibwe A, Oryokot B, Mugenyi L, et al. Incidence of tuberculosis among PLHIV on antiretroviral therapy who initiated isoniazid preventive therapy: a multi-center retrospective cohort study. PLoS One. 2022;17(5):1–13. doi:10.1371/journal.pone.0266285
- Russom M, Woldu HG, Berhane A, Jeannetot DYB, Stricker BH, Verhamme K. Effectiveness of a 6-month isoniazid on prevention of incident tuberculosis among people living with HIV in Eritrea: a retrospective cohort study. Infect Dis Ther. 2022;11(1):559–579. doi:10.1007/s40121-022-00589-w
- Darraj MA, Abdulhaq AA, Yassin A, et al. Tuberculosis among people living with HIV/AIDS in Jazan Region, Southwestern Saudi Arabia. J Infect Public Health. 2021;14(11):1571–1577. doi:10.1016/j.jiph.2021.09.009
- Ahmed A, Mekonnen D, Shiferaw AM, Belayneh F, Yenit MK. Incidence and determinants of tuberculosis infection among adult patients with HIV attending HIV care in north-east Ethiopia: a retrospective cohort study. BMJ Open. 2018;8(2):e016961. doi:10.1136/bmjopen-2017-016961
- Mebratu W, Wedajo S, Mohammed S, Endawkie A, Damtew Y. Prevalence and associated factors of tuberculosis among isoniazid users and non-users of HIV patients in Dessie, Ethiopia. Sci Rep. 2022;12(1):1–10. doi:10.1038/s41598-022-16437-3.